Stockscreener 앱 받기
2.74
3.86%
-0.11
시간 외 거래:
2.74
전일 마감가:
$2.85
열려 있는:
$2.83
하루 거래량:
3.88M
Relative Volume:
0.67
시가총액:
$2.43B
수익:
$1.31M
순이익/손실:
$-597.65M
주가수익비율:
-2.8247
EPS:
-0.97
순현금흐름:
$-425.62M
1주 성능:
-2.49%
1개월 성능:
-9.57%
6개월 성능:
-23.03%
1년 성능:
-49.63%
1일 변동 폭
$2.69
$2.87
1주일 범위
$2.68
$2.885
52주 변동 폭
$2.28
$10.53
Immunitybio Inc Stock (IBRX) Company Profile
명칭
Immunitybio Inc
전화
(844) 696-5235
주소
3530 JOHN HOPKINS COURT, SAN DIEGO
IBRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
2.74 | 2.43B | 1.31M | -597.65M | -425.62M | -0.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
509.04 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.14 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
605.52 | 36.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
280.96 | 36.37B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
250.47 | 27.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-06 | 개시 | H.C. Wainwright | Buy |
| 2025-01-10 | 개시 | BTIG Research | Buy |
| 2023-05-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | 개시 | Jefferies | Buy |
Immunitybio Inc 주식(IBRX)의 최신 뉴스
Is ImmunityBio, Inc. (NASDAQ:IBRX) The Top Penny Stock That Will Skyrocket? - Insider Monkey
Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, - GlobeNewswire
Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, PLLP Investigates - EIN News
ImmunityBio appoints Deloitte as new auditor By Investing.com - Investing.com South Africa
ImmunityBio appoints Deloitte as new auditor - Investing.com Australia
Drugmaker's $10.5M Deal In Investor FDA Approval Suit OK'd - Law360
ImmunityBio $10.5 Million Settlement Over Record Selloff Gets OK - Bloomberg Law
From cancer vaccines to COPD treatments, these 10 companies are developing innovative medicines - Fast Company
ImmunityBio ($IBRX) Is Paying a $10.5M Settlement to Investors — Here’s How to Get Your Share - TradingView
H.C. Wainwright maintains $8 target for ImmunityBio stock By Investing.com - Investing.com Australia
H.C. Wainwright maintains $8 target for ImmunityBio stock - Investing.com
Recombinant BCG Vaccine Becomes Available in the U.S. - Precision Vaccinations
ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching - BioSpace
ImmunityBio Partner US Urology Begins Administering rBCG to Address Tice BCG Shortage - Marketscreener.com
ImmunityBio, Inc. (IBRX): Among the Stocks Under $10 With High Upside Potential - Insider Monkey
ImmunityBio (IBRX) Expected to Announce Earnings on Tuesday - Defense World
SBI Securities Co. Ltd. Buys New Position in ImmunityBio, Inc. (NASDAQ:IBRX) - Defense World
Q1 Earnings Forecast for ImmunityBio Issued By HC Wainwright - Defense World
Private Advisor Group LLC Cuts Stock Position in ImmunityBio, Inc. (NASDAQ:IBRX) - Defense World
HC Wainwright Begins Coverage on ImmunityBio (NASDAQ:IBRX) - Defense World
ImmunityBio: BCG Shortage And Tariff Risks Could Stifle Anktiva's Commercial Momentum - Seeking Alpha
H.C. Wainwright sets $8 target for ImmunityBio stock, rates Buy By Investing.com - Investing.com South Africa
ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug - Benzinga India
This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - Benzinga India
H.C. Wainwright sets $8 target for ImmunityBio stock, rates Buy - Investing.com
HC Wainwright Initiates Coverage on ImmunityBio With Buy Rating, $8 Price Target -March 06, 2025 at 07:26 am EST - Marketscreener.com
HC Wainwright & Co. Initiates Coverage of ImmunityBio (IBRX) with Buy Recommendation - Nasdaq
H.C. Wainwright starts coverage of ImmunityBio with 'buy' rating - TradingView
Earnings Update: ImmunityBio, Inc. (NASDAQ:IBRX) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts - Simply Wall St
New York State Common Retirement Fund Grows Position in ImmunityBio, Inc. (NASDAQ:IBRX) - Defense World
ImmunityBio (NASDAQ:IBRX) Trading Up 6.8% Following Strong Earnings - Defense World
Why ImmunityBio Inc. (IBRX) Crashed on Monday - MSN
ImmunityBio Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
ImmunityBio: Q4 Earnings Snapshot - Barchart
ImmunityBio, Inc. (NASDAQ:IBRX) Shares Bought by Handelsbanken Fonder AB - Defense World
ImmunityBio’s Sales Surge Amid Strategic Advances - TipRanks
ImmunityBio stock rises on Q4 earnings beat, revenue growth - Investing.com India
Why ImmunityBio, Inc. (IBRX) Soared on Friday - MSN
ImmunityBio stock rises on Q4 earnings beat, revenue growth By Investing.com - Investing.com South Africa
Immunitybio Inc earnings beat by $0.08, revenue topped estimates - Investing.com South Africa
ImmunityBio (IBRX) Reports Q4 Loss, Misses Revenue Estimates - MSN
ImmunityBio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
ImmunityBio Reports Sales Momentum & Unit Growth Since Permanent J-code Issuance (J9028) in January 2025 and Financial Results for Year End 2024 - BioSpace
Immunitybio Inc (IBRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
0.03%
자본화:
|
볼륨(24시간):